Molecular detection of early appearance of drug resistance during Mycobacterium tuberculosis infection

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 9, 2002, Pages 876-881

  Victor, Thomas C ^a   Lee, Hyeyoung ^a   Cho, Sang Nae ^a   Jordaan, Annemarie M ^a   van der Spuy, Gian ^a   van Helden, Paul D ^a   Warren, Robin ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Drug resistance; Mutations; Tuberculosis

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; PRIMER DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; DOT HYBRIDIZATION; EARLY DIAGNOSIS; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PATIENT COMPLIANCE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WILD TYPE; ANALYTICAL EQUIPMENT; CLASSIFICATION; COMPARATIVE STUDY; DNA PROBE; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA PROBES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0036408718     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.155     Document Type: Article

References (22)

1. Culliton BJ. Drug-resistant TB may bring epidemic. Nature 1992; 356:473.
2. Shinnick TM, Jones V. Molecular approaches to the diagnosis of tuberculosis. In: BR Bloom, editor. Tuberculosis: pathogenesis, protection and control. Washington, DC: ASM Press, 1994:517-30.
3. Tarrand JJ, Groschel DH. Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol 1985; 21:941-6.
4. Victor TC, Jordaan AM, van Rie A, van der Spuy GD, Richardson M, van Helden PD, et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis 1999; 79:343-8.
5. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79:3-29.
6. Heym B, Honore N, Truffot-Pernot C, Banerjee A, Schurra C, Jacobs WR, Jr. et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994; 344:293-8.
7. Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995; 171:954-60.
8. Felmlee TA, Liu Q, Whelen AC, Williams D, Sommer SS, Persing DH. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995; 33:1617-23.
9. Williams DL, Waguespack C, Eisenach K, Crawford JT, Portaels F, Salfinger M, et al. Characterization of rifampicin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994; 38:2380-6.
10. Wengenack NL, Uhl JR, St Amand AL, Tomlinson AJ, Benson LM, Naylor S, et al. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis 1997; 176:722-7.
11. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647-50.
12. De Beenhouwer H, Lhiang Z, Jannes G, Mijs W, Machtelinckx L, Rossau R, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995; 76:425-30.
13. Rossau R,Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother 1997; 41:2093-8.
14. Bradford WZ, Martin JN, Reingold AL, Schecter GF, Hopewell PC, Small PM. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996; 348:928-31.
15. Frieden TR, Sterling T, Pablos-Menclez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-6.
16. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. J Am Med Assoc 1993; 270:65-8.
17. Kleeberg HH, Blackblock Z, Boulahbal F, David HL, Fink H, Gatner EMS, et al. A simple method of testing drug susceptibility of Mycobacterium tuberculosis: a report of an international collaborative study. Bull Int Union Tuberc 1985; 60:147-50.
18. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17:2503-16.
19. van Rie A, Warren R, Mshanga I, Jorclaan AM, van der Spuy GD, Richardson M, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001; 39:636-41.
20. Persing DH, Smith TF, Tenover FC, White TJ. In vitro nucleic acid amplification techniques. Diagnostic molecular microbiology: principles and applications. Washington DC: ASM Press, 1993:3-160.
21. Rinder H, Mieskes KT, Loscher T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001; 5:339-45.
22. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36:1969-73.